NanoSurface Bio

NanoSurface Bio is a privately held company based in Seattle, Washington. Employing 9 people, the company generates approximately $5 million in annual revenue. NanoSurface Bio specializes in developing and providing cutting-edge tools for a range of scientific research applications. Their product portfolio includes NanoSurface Cultureware, featuring biomimetic nanotopographic surfaces that mimic the extracellular matrix, NanoSurface Cytostretcher, a system for applying programmable stretch routines to cell cultures, and the NanoSurface eCyte 6, an electrical stimulation system for in vitro cell stimulation. Additionally, they offer the NanoSurface Car(ina) platform for pre-clinical drug screening using human stem cell-derived heart tissues. These products cater to researchers in fields such as cell and tissue engineering, drug discovery, disease modeling, and fundamental cell biology. NanoSurface Bio distinguishes itself through its innovative approach to cell culture technology. Their products are designed to enhance the physiological relevance of in vitro research by incorporating biomimetic features that promote cell organization, migration, and phenotypic development, leading to more accurate and reliable experimental results. For further information or inquiries, please visit NanoSurface Bio's website at nanosurfacebio.com.